Form 8-K - Current report:
SEC Accession No. 0001104659-25-067451
Filing Date
2025-07-11
Accepted
2025-07-11 17:14:16
Documents
16
Period of Report
2025-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520607d1_8k.htm   iXBRL 8-K 43210
2 EXHIBIT 99.1 tm2520607d1_ex99-1.htm EX-99.1 12955
3 EXHIBIT 99.2 tm2520607d1_ex99-2.htm EX-99.2 10055
7 GRAPHIC tm2520607d1_ex99-1img001.jpg GRAPHIC 3013
8 GRAPHIC tm2520607d1_ex99-2img001.jpg GRAPHIC 2717
  Complete submission text file 0001104659-25-067451.txt   249679

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20250707.xsd EX-101.SCH 3035
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20250707_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20250707_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2520607d1_8k_htm.xml XML 3345
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 251119663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)